Dr Harikrishnan Anjaly Sukumaran Nair
Hari completed his doctoral studies on the molecular mechanisms of multispecies bacterial biofilm development from the Singapore Biofilm center. Upon winning an innovation challenge from Johnson & Johnson consumer care, Hari relocated to Germany to work for the biotech start-up company BiomedX GmbH. During his time at BiomedX, he developed a new oral hygiene product which can remove dental biofilms without destroying the enamel. In April, 2019 Hari joined the Vogel lab developing a new generation of programmable antibiotics using RNA antisense technology.